LSV Asset Management Boosts Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

LSV Asset Management boosted its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD – Get Rating) by 17.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,814 shares of the medical instruments supplier’s stock after buying an additional 1,913 shares during the quarter. LSV Asset Management owned 0.35% of Utah Medical Products worth $1,288,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Acadian Asset Management LLC bought a new stake in shares of Utah Medical Products in the first quarter valued at about $40,000. BNP Paribas Arbitrage SA raised its holdings in Utah Medical Products by 97.7% in the second quarter. BNP Paribas Arbitrage SA now owns 779 shares of the medical instruments supplier’s stock worth $67,000 after purchasing an additional 385 shares in the last quarter. Lazard Asset Management LLC raised its holdings in Utah Medical Products by 21.3% in the first quarter. Lazard Asset Management LLC now owns 837 shares of the medical instruments supplier’s stock worth $75,000 after purchasing an additional 147 shares in the last quarter. BNP Paribas Arbitrage SNC raised its holdings in Utah Medical Products by 33.5% in the third quarter. BNP Paribas Arbitrage SNC now owns 1,040 shares of the medical instruments supplier’s stock worth $89,000 after purchasing an additional 261 shares in the last quarter. Finally, MetLife Investment Management LLC raised its holdings in Utah Medical Products by 57.0% in the first quarter. MetLife Investment Management LLC now owns 2,030 shares of the medical instruments supplier’s stock worth $182,000 after purchasing an additional 737 shares in the last quarter. 70.04% of the stock is owned by hedge funds and other institutional investors.

Utah Medical Products Trading Up 0.1 %

Utah Medical Products stock opened at $91.65 on Monday. Utah Medical Products, Inc. has a 12 month low of $80.10 and a 12 month high of $109.50. The stock’s 50 day simple moving average is $93.28 and its two-hundred day simple moving average is $92.81. The firm has a market cap of $332.51 million, a PE ratio of 19.46 and a beta of 0.19.

Utah Medical Products Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 6th. Stockholders of record on Friday, June 16th will be paid a dividend of $0.295 per share. This represents a $1.18 annualized dividend and a dividend yield of 1.29%. The ex-dividend date is Thursday, June 15th. Utah Medical Products’s payout ratio is 25.05%.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Utah Medical Products in a research note on Thursday, March 16th. They set a “strong-buy” rating on the stock.

Utah Medical Products Company Profile

(Get Rating)

Utah Medical Products, Inc engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology.